Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRT-201 in AVF Creation for CKD
NCT00679991Phase 2Completed
- Sponsor
- Proteon Therapeutics
- Start
- Nov 2008
- Primary completion
- Jul 2011
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of vonapanitase in arteriovenous fistula (AVF), sponsored by Proteon Therapeutics. Started Nov 2008; status: completed.
02
Drugs
vonapanitase
03
Conditions
arteriovenous fistula (AVF)
Beyond the preview
Go deeper on NCT00679991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679991.